Details for New Drug Application (NDA): 050703
✉ Email this page to a colleague
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
Summary for 050703
Tradename: | BACTROBAN |
Applicant: | Glaxosmithkline |
Ingredient: | mupirocin calcium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;NASAL | Strength | EQ 2% BASE | ||||
Approval Date: | Sep 18, 1995 | TE: | RLD: | Yes |
Expired US Patents for NDA 050703
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription